Cytolethal distending toxin enhances Escherichia coli urinary tract infection
Abstract
ABSTRACT Cytolethal distending toxin (CDT) is a virulence factor produced by several gram-negative bacteria, including Escherichia coli, the most prevalent etiological agent of urinary tract infections (UTIs). CDT causes DNA damage to eukaryotic cells, leading to the impairment of host defenses by disrupting epithelial barriers, suppressing acquired immunity, and promoting pro-inflammatory responses. E. coli strains encoding CDT have been previously identified in samples from UTI patients; however, the specific function of CDT in the development of UTI remains undefined. In this study, we used a mouse model of ascending UTI to determine the role of CDT during infection. An E. coli mutant strain lacking the cdtABC locus was generated and combined with wild-type bacteria to co-infect mice via transurethral inoculation. At 1 day post-inoculation, competitive indices demonstrated a significant disadvantage for the cdt mutant in urine, bladder, and kidneys. Single-strain infections were also performed as a further assessment of CDT impact, demonstrating that the cdt mutant had reduced kidney colonization, indicative of CDT contributions to pyelonephritis. Histopathological analysis of the urinary bladder and kidney tissues from mice infected with CDT-encoding E. coli demonstrated higher levels of inflammation and tissue damage within the kidneys at both 1 and 7 days post-inoculation and in the bladder after 7 days when compared to mice infected with cdt mutant bacteria.…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.